ScanGrants - Diabetes

Call for Nominations: 2014 Richard R. Rubin Award

Call for Nominations: 2014 Richard R. Rubin Award

Deadline: October 18, 2013

Formerly the Behavioral Medicine & Psychology Interest Group Lectureship for Distinguished Contributions, the Richard R. Rubin Award Lecture is given in memory of Richard R.Rubin, PhD, CDE, a long time Association volunteer, who served as President, Health Care and Education, and chair of the Council on Behavioral Medicine &
Psychology, and received numerous professional and service awards. Specifically, the Richard R. Rubin Award
recognizes a behavioral researcher who has made outstanding and/or innovations contributions in the study and understanding of the behavioral aspects of diabetes.

Criteria for Selection:

• Principal criteria for selection: To recognize a behavioral researcher who has made outstanding and/or innovative contributions in the study and understanding of behavioral aspects of diabetes.

• Nominee will be recognized for national and/or international contributions to the field of behavioral medicine in diabetes

• Nominee must be an active American Diabetes Association member.

• No specific degree requirements, but a clinical/research focus in behavioral health is strongly preferred

• Both U.S. and non-U.S. residents are eligible for Award.

• Contributions as an Amer ican Diabetes Association volunteer and to the broader diabetes community may also be taken into consideration.

Award/Lecture/Publication:

• The recipient will deliver a lecture as part of a featured symposium at the Association’s Annual 74th Scientific Sessions, June 13-17, 2014 in San Francisco, CA.

• The recipient will lead a discussion related to the topic of the lectureship presentation at the Council Discussion
Session during the meeting

Honoraria/Award:

• Award includes a $1,000 honorarium.

• Award includes complimentary hotel accommodations for up to 3-nights within Association hotel block and
round-trip coach airfare for the recipients

• Includes one complimentary registration to Scientific Sessions

Should you need assistance with your nomination, please contact Mary Merkin at mmerkin@diabetes.org or call 800-676-4065, ext 1371.

Call for Nominations: American Diabetes Association 2014 Kelly M. West Award

Call for Nominations: American Diabetes Association 2014 Kelly M. West Award

Deadline: October 18, 2013.

Award Profile:

Given in memory of Kelly M. West, widely regarded as the “father of diabetes epidemiology”, to an individual who has made significant contributions to the field of diabetes epidemiology.

Criteria for Selection:

• Principal criteria for selection process: impact of scientific publications and presentations at scientific meetings related to the epidemiology of diabetes.

• Also, national and international stature in the field of diabetes epidemiology.

• Also, impact as a teacher and mentor will also be taken into consideration.

• MD, PhD, or MPH degree or equivalent is required.

• Both U.S. and non-U.S. residents are eligible for award.

• Contributions and volunteer service to both national and international diabetes organizations and the broader diabetes community may also be taken into consideration.

Award/Lecture/Publication:

• The recipient will deliver a lecture at the Annual Scientific Sessions.

• Offered the opportunity to publish the lecture in an American Diabetes Association journal.

Honoraria/Award:

• The recipient receives a $3,000 honorarium.

• Award includes round-trip coach airfare for winner and spouse and hotel stay for up to 5-nights. Also include other meeting related and travel expenses.

• Includes complimentary registration to Scientific Sessions, June 13-17, 2014, for winner and a family member.

Nominations Process:

• Nominations must be submitted using the universal 2014 Nomination Form.

• Nominations are accepted from any professional member of the American Diabetes Association.

• Nominations from the membership of the Epidemiology and Statistics Interest Group especially will be solicited.

• Letter of nomination (no more than 400 words, signed by no more than 3 individuals).

• Application letter or nomination letter should address criteria for selection (above).

• CV with career, mentoring, and publication highlights.

• Please include a list of current and former Mentees/Trainees.

The recipient is chosen by the Medicine, Science and Health Care Awards Committee and approved by the Executive Committee of the American Diabetes Association, February 2014.

Should you need assistance with your nomination, please contact Mary Merkin at mmerkin@diabetes.org or call 800-676-4065, ext 1371.

Call for Nominations: 2014 Harold Rifkin Award for Distinguished International Service in the Cause of Diabetes

Call for Nominations: 2014 Harold Rifkin Award for Distinguished International Service in the Cause of Diabetes

Deadline: October 18, 2013.

Award Profile:

Given in memory of Harold Rifkin, to honor outstanding service in the cause of diabetes that has been performed with an international perspective and with international impact, this award recognizes those whose efforts have increased the awareness of the burden of diabetes worldwide to improve the care and lives of those with diabetes. Dr. Rifkin’s work specifically supported efforts to increase awareness of the burden of diabetes worldwide and in establishing relationships across diabetes organizations.

Criteria for Selection:

• Nominee will demonstrate long-term volunteer service to one or more diabetes-related organizations.

• Broad professional expertise and contributions in diabetes may be recognized – including, but not exclusive to clinical care, research, education, health policy and advocacy.

• Both U.S. and non-U.S. residents are eligible for award.

• Contributions and volunteer service to both national and international diabetes organizations and the boarder diabetes community may also be taken into consideration.

Award Lecture/Publication:

• None

Honoraria/Award:

• The recipient receives a $3,000 honorarium.

• Award includes round-trip coach airfare for winner and spouse and hotel stay for up to 5-nights. Also include other meeting related and travel expenses.

• Includes complimentary registration to Scientific Sessions, June 13-17, 2014, for winner and a guest.

Nomination/Submission Process:

• Nominations must be submitted using the universal 2014 Nomination Form.

• Nominations are accepted from any professional member of the American Diabetes Association.

• Letter of nomination (no more than 400 words) signed by no more than 3 individuals will be accepted.

• Application letter or nomination letter should address criteria for selection (above).

• Nominee’s CV with career highlights and documentation of international contribution.

• Please include a biography.

Selection Process:

The recipient is chosen by the Medicine, Science and Health Care Awards Committee and approved by the Executive Committee of the American Diabetes Association, February 2014.

Should you need assistance with your nomination, please contact Mary Merkin at mmerkin@diabetes.org or call 800-676-4065, ext 1371.

Call for Nominations: American Diabetes Association 2014 Outstanding Physician-Clinician Award

Call for Nominations: American Diabetes Association 2014 Outstanding Physician-Clinician Award

Deadline: October 18, 2013

Award Profile:

To recognize a physician for outstanding achievements in improving diabetes clinical practice.

Criteria for Selection:

• Nominee is actively involved in the clinical care of patients with diabetes.

• Nominee is recognized and highly regarded as a clinician and educator of health care professionals with >10 years of distinguished service.

• Nominee is well-known nationally or internationally for exceptional clinical knowledge and expertise.

• Nominee has outstanding track record of sharing his/her expertise with other health care professionals as documented by presentations and/or authorship of books /articles/reference materials

• Nominee is a current member of the Association’s Professional Section.

• Both U.S. and non-U.S. residents are eligible for award.

• Contributions and volunteer service to both national and international diabetes organizations and the broader diabetes community may also be taken into consideration.

Award/Lecture/Publication:

• None

Honoraria/Award:

• The recipient receives a $3,000 honorarium

• Award includes round-trip coach airfare for winner and spouse and hotel stay for up to 5-nights. Also include other meeting related and travel expenses

• Award Includes complimentary registration to Scientific Sessions, June 13-17, 2014, for winner and a guest.

Nomination/Submission Process:

• Nominations must be submitted using the universal 2014 Nomination Form.

• Nominations are accepted from any professional member of the American Diabetes Association.

• Letter of nomination (no more than 400 words, signed by no more than 3 individuals)

• Nomination letter should address criteria for selection (above)

• Nominee’s CV with career and publication highlights. Please include a biography.

Should you need assistance with your nomination, please contact Mary Merkin at mmerkin@diabetes.org or call 800-676-4065, ext 1371.

Call for Nominations: 2014 Outstanding Educator in Diabetes Award

Call for Nominations: 2014 Outstanding Educator in Diabetes Award

Deadline: October 18, 2013

Award Profile:

To stimulate, acknowledge and reward outstanding educational efforts by health professionals in the field of diabetes education.

Criteria for Selection:

• Nominee will have demonstrated significant, long-term national or international contributions to the field of diabetes education.

• Nominee will have many years of effort in the field of diabetes education and will have evidence of benefit to recipients.

• Nominee should be well-known to others in his/her area of expertise.

• Publications and teaching experience are factors in the selection process.

• Nominee must be a member of the National Professional Section.

• Both U.S. and non-U.S. residents are eligible for award.

• Contributions and volunteer service to both national and international diabetes organizations and the broader diabetes community may also be taken into consideration.

Award/Lecture/Publication:

• Recipient will deliver the Outstanding Educator Lecture at the annual 74th

• Recipient is offered the opportunity to publish the lecture in an ADA Journal. Scientific Sessions, June 13-17, 2014 in San Francisco, CA.

Honoraria/Award:

• The recipient receives a $3,000 honorarium.

• Award includes round-trip coach airfare for winner and spouse and hotel stay for up to 5-nights. Also include other meeting related and travel expenses.

• Award Includes complimentary registration to Scientific Sessions for winner and a family member.

Nomination/Submission Process:

• Nominations must be submitted using the universal 2014 Nomination Application Form.

• Nominations are accepted from any professional member of the American Diabetes Association.

• Letter of nomination (no more than 400 words) signed by no more than 3 individuals will be accepted.

• Nomination letter should address criteria for selection (above).

• Nominee’s CV with career and publication highlights. Please include a biography.

Selection:

The recipient is chosen by the Medicine, Science, and Health Care Awards Committee and approved by the Executive Committee of the American Diabetes Association, February 2014.

Should you need assistance with your nomination, please contact Mary Merkin at mmerkin@diabetes.org or call 800-676-4065, ext 1371.

Call for Nominations: American Diabetes Association Outstanding Scientific Achievement Award

Call for Nominations: American Diabetes Association Outstanding Scientific Achievement Award

Deadline to submit nominations is October 18, 2013

Purpose of Award:

• To recognize outstanding scientific achievement in diabetes research, taking into consideration independence of thought, originality, significance of discovery, and impact on his/her area of research.

Criteria for Selection:

• Nominee will have demonstrated significant, independent contribution in their selected area of diabetes research, including diabetes pathogenesis, treatment and/or prevention.

• Nominee must be actively engaged in some aspect of diabetes research at the time the award is given.

• Nominee must be less than 50 years of age on January 1 of the award year.

• Nominee must have MD, PhD degree or equivalent.

• Both U.S. and non-U.S. residents are eligible for award.

• Contributions and volunteer service to both national and international diabetes organizations and the broader diabetes community may also be taken into consideration.

Award/Lecture/Publication:

• Recipient will deliver the Outstanding Scientific Achievement Award (OSAA) Lecture at the 74th Scientific Sessions in San Francisco, CA, June 13-17, 2014.

• Is offered the opportunity to publish the lecture in an ADA Journal.

Honoraria/Award:

• The recipient receives a $10,000 honorarium.

• Offered the opportunity to publish the lecture in an American Diabetes Association journal.

• Award includes round-trip coach airfare for winner and spouse and hotel stay for up to 7-nights. Also include meeting and other travel related expenses.

• Includes complimentary registration Scientific Sessions for winner and a family member.

Nomination/Submission Process:

• Nominations must be submitted using the universal 2014 National Scientific Achievement Award Application form.

• Nominations are accepted from any professional member of the American Diabetes Association.

• Letter of nomination (no more than 400 words), signed by no more than 3 individuals, will be accepted. Letter of nomination should address criteria for selection.

• Nominee’s biography, CV with career and publication highlights.

• Please provide date of birth.

• Annotated list of the nominee’s 5 most significant publications.

Selection: The recipient is chosen by the Medicine, Science, and Health Care Awards Committee and approved by the Executive Committee of the American Diabetes Association, February 2014.

Should you need assistance with your nomination, please contact Mary Merkin at mmerkin@diabetes.org or call 800-676-4065, ext 1371.

Call for Nominations: American Diabetes Association 2014 Banting Medal for Scientific Achievement Award

Call for Nominations: American Diabetes Association 2014 Banting Medal for Scientific Achievement Award

Deadline: October 18, 2013

The Banting Medal for Scientific Achievement Award is the highest scientific award of the American Diabetes Association. Given in memory of Sir Frederick Banting, a medical scientist, doctor and Nobel laureate who is noted as one of the key investigators in the discovery of insulin, the Banting Medal is awarded annually to honor highly meritorious career achievement in the field of diabetes research.

Criteria for Selection:

• Nominee will have demonstrated significant, long-term contribution to the understanding of diabetes, its treatment and/or prevention.

• Publications and teaching experience are primary factors in the selection process.

• Nominee must have MD, PhD degree or equivalent.

• Both U.S. and non-U.S. residents are eligible for award.

• Contributions and volunteer service to both national and international diabetes organizations and the broader diabetes community may also be taken into consideration.

Award/Lecture/Publication:

• Recipient will deliver the Banting Lecture at the 74th Scientific Sessions in San Francisco, June 13-17, 2014.

• Is offered the opportunity to publish lecture in an ADA Journal.

Honorarium/Award:

• The recipient receives a $20,000 honorarium.

• Offered the opportunity to publish the lecture in an American Diabetes Association journal.

• Award includes round-trip coach airfare for winner and spouse and hotel stay for up to 7-nights. Also include other travel related expenses.

• Includes complimentary registration to Scientific Sessions for winner and a family member.

Should you need assistance with your nomination, please contact Mary Merkin at mmerkin@diabetes.org or call 800-676-4065, ext 1371.

Fellowships for Health Journalists to Cover the 44th Union World Conference on Lung Health in Paris, France

Fellowships for Health Journalists to Cover the 44th Union World Conference on Lung Health in Paris, France

October 29 -31, 2013, Paris, France

Application Deadline: July 22, 2013

The Journalist to Journalist Project of the National Press Foundation is working with the International Union Against Tuberculosis and Lung Disease to offer all-expenses-paid fellowships for health journalists to cover the 44th Union World Conference on Lung Health in Paris, France. Fellowship winners will attend three days of expert training from Tuesday to Thursday, 29-31 October, then cover the conference through Sunday, 3 November 2013.

The three-day J2J programme is designed for working journalists who want to increase their knowledge and skill at developing stories on lung health and related issues, including tuberculosis; TB/HIV; asthma, COPD, diabetes, tobacco control and the impact of air pollution. Journalists will share their own work and hear presentations from world-class experts on these diseases, the extent and impact of the problems they present (including social, political and economic impacts) and new research, solutions and innovations in the pipeline. The sessions will provide presentations and discussions with experts, as well as practical training in turning scientific information into effective print and broadcast stories.

Applications are sought from journalists working in any medium. Special though not exclusive attention will be given to applications from journalists in low- and middle-income countries, along with China, India, Russia and South Africa. Up to 20 fellowships will be awarded. Each will cover conference registration, round-trip air and train travel, hotel accommodation and per diem.

All applicants must have been working as a journalist covering lung health or general health for at least three years. All J2J sessions will be in English, so proficient spoken and written English are essential.

The deadline for applications is 5:00 PM EST, July 22, 2013. Only online applications are accepted.

The Union World Conference on Lung Health is the largest annual conference focusing on lung health issues as they affect low- and middle-income countries. The theme of this year’s conference is “Shared Air, Safe Air?” More than 3,000 delegates from 120+ countries are expected to attend. (For more details, www.worldlunghealth.org)

This program is sponsored by The Lilly MDR-TB Partnership and The International Union Against Tuberculosis and Lung Disease

American Diabetes Association Innovation Award

American Diabetes Association Innovation Award

Application Deadline:  July 15, 2013 for January 2014 funding

These pilot and feasibility grants are designed to support novel hypotheses that may lack preliminary data, but offer considerable promise for the cure, prevention, or treatment of diabetes.

Support: Awards provide a maximum of $50,000 per year for up to two years, including 10% allowable indirect costs. Up to $10,000/year may be requested for PI salary support.

American Diabetes Association Translational Science Award

American Diabetes Association Translational Science Award

Application Deadline: July 15, 2013 for January 2014 funding

Translational Science Awards support research that accelerates the transition of scientific discoveries into clinical applications by efficiently advancing knowledge of efficacy to the next level of clinical application. Translational research supported with these awards will typically involve expertise, collaboration and engagement across disciplines.

Support: Awards provide up to $200,000 per year for up to three years, including 15% allowable indirect costs. Up to 20% of total costs may be requested for PI salary support.

American Diabetes Association Clinical Science and Epidemiology Award

American Diabetes Association Clinical Science and Epidemiology Award

Application Deadline:  July 15, 2013 for January 2014 funding

Clinical Science and Epidemiology Awards are designed to support patient-oriented clinical research and epidemiology research in diabetes.

Support:  Awards provide up to $200,000 per year for up to three years, including 15% allowable indirect costs. Up to 20% of total costs may be requested for PI salary support.

American Diabetes Association Basic Science Award

American Diabetes Association Basic Science Award

Application Deadline: July 15, 2013 for January 2014 funding

These awards offer grant support to both new and established investigators. Applications will be considered in any area that is relevant to the etiology or pathophysiology of diabetes and its complications.

Support: Awards provide up to $115,000 per year for up to three years, including 15% allowable indirect costs. Up to 20% of total costs may be requested for PI salary support.

American Diabetes Association and Merck Clinical/Translational Science Postdoctoral Fellowship Award

American Diabetes Association and Merck Clinical/Translational Science Postdoctoral Fellowship Award

Application Deadline:  July 15, 2013 for January 2014 funding

The purpose of the American Diabetes Association-Merck Clinical/Translational Science Postdoctoral Fellowship Award is to support the training of clinical diabetes investigators in the area of clinical/translational research. The award will be given to an established and active clinical diabetes investigator (Mentor/PI) in diabetes research for the annual stipend support of a postdoctoral fellow to work closely with the mentor. The focus on outcomes research will help to further outcomes research as an important area and spur more to see it as a viable career path.

Support:

Awards provide up to $75,000 per year for two years. Funds are to be used for the stipend support of a single clinical/translational postdoctoral fellow in a given year, as well as laboratory supplies and travel costs.

Requests for Applications: Biomarkers of Pancreatic Beta Cell Stress and Health

Requests for Applications: Biomarkers of Pancreatic Beta Cell Stress and Health

JDRF, the world’s leading non-profit organization with the mission to cure type 1 diabetes (T1D), invites applications from research investigators having interest and expertise to support the discovery and advancement of biomarkers of pancreatic beta cell stress and health correlating with early beta-cell loss.

The purpose of this call for Letters of Intent is to invite proposals to support and advance the discovery, development, and/or validation of biomarkers of pancreatic beta cell stress and dysfunction. Studies based on use or validation with human beta cells/islets and clinical samples or tissues will be of special interest.

MECHANISM

Applications in response to this announcement can be submitted under one of the following funding mechanisms:
Pilot & Feasibility Grants (P&Fs): up to $110,000 (including 10% indirect costs) for one year only.

Strategic Research Agreements (SRAs): Up to $250,000 USD per year including 10% indirect costs
for up to 3 years may be requested. The level of funding will vary depending on the scope and overall objectives of the proposal. Under the terms of the grant award, written quarterly (~2-3 pages) reports will be required from the funded investigator as a basis for continued support.

LETTER OF INTENT

Prospective applicants should submit a letter of intent on -line via the proposalCENTRAL website (https://proposalcentral.altum.com/default.asp).

The LOI template provided on the proposalCENTRAL Web site must be used to complete the application. Applicants will be notified approximately eight weeks after the LOI deadline date if they have been approved to submit a full application.

Letter of Intent Deadline: June 17, 2013.

American College of Cardiology Foundation/Merck Research Fellowships in Cardiovascular Disease

American College of Cardiology Foundation/Merck Research Fellowships in Cardiovascular Disease

Four one-year fellowships will be awarded to support research in adult cardiology. Preference is given to individuals who have had no more than two years of prior full-time experience either in clinical or basic research. Recipients will be expected to pursue a full-time project in clinical research during their year of supported training.

Research Focus: In selecting applications, proposals addressing CVD and Cardiometabolic disorders are encouraged. Included are proposals that address pathophysiology, molecular genetics, metabolic abnormalities leading to cardiovascular disease, hypertension, heart failure, hyperlipidemia, inflammatory mechanisms and new pathways for drug discovery. Proposals focusing on clinically relevant outcomes as a result of the metabolic syndrome, diabetes or obesity are also encouraged. Outcomes studies should focus on clinical/and or systems of care (e.g., quality improvement) interventions, and use outcomes measures of importance to both patients and society, including mortality, significant morbidity or quality of life changes, or economic effects.

Preference for one award will be given to applicants focusing on disparities of care.  Despite increased attention to health disparities at the national, state and community levels, relatively little progress has been made in achieving the vision of eliminating racial and ethnic health disparities.  Since the rates of cardiovascular mortality in the United States are significantly higher for these patients and this is, in fact, the leading cause of death in this demographic, innovative approaches to eliminating these disparities are critical.  In an effort to encourage and support research in this area, proposals will be encouraged that focus on gender, race, geographic, and economic inequalities in cardiovascular care.

Eligibility: Anyone currently in an adult cardiology fellowship training program recognized by the Accreditation Council for Graduate Medical Education or the American Osteopathic Association and who has the recommendation and agreement of his/her training program director and institution.

Selection: Judging will be by the ACCF/Research Fellowship Awards Committee. Criteria for selection will include:

• Scientific quality of the project;

• Relevance to the research focus as described above;

• Qualifications and commitment of the applicant; and

• The quality of the training environment.

Successful applicants may pursue this protected year of research either within or following their three years of required training. Preference will be given to individuals who:

• Will pursue clinical research training and experience directly involving patients or human subjects.

• Have had no more than two years of prior full-time research experience either in clinical or basic research.

• Will not hold another major external fellowship or salary award, (e.g., from the National Institutes of Health or the American Heart Association) during the ACCF/Merck funded year.

The Award: Four fellowships in the amount of $70,000 each, to be used for salary support, for one year of research to begin July 1, 2014 and run through June 30, 2015.

Funding Source: The ACCF is grateful to the Merck Company Foundation for their continued financial support for these awards.

Deadline: September 23, 2013

For more information: Email Julia Berman or call 800-253-4636, ext. 6648.

Request for Proposals: 2013 ASPIRE Awards in Adult Vaccine Research

Request for Proposals: 2013 ASPIRE Awards in Adult Vaccine Research

Mission

The mission of the 2013 ASPIRE Awards in Adult Vaccine Research is to advance medical knowledge to better understand the burden of pneumococcal disease in adults.

The burden of pneumococcal disease in the general adult population has been extensively studied; however, it is not well-defined in special populations, including subgroups with underlying disease comorbidities and/or those living in long-term community settings.

Pfizer invites investigators to apply for the 2013 ASPIRE Awards in Adult Vaccine Research through submission of innovative research proposals for evaluation of the epidemiology and burden of pneumococcal disease in adults with underlying disease comorbidities and/or those living in long-term community settings.

2013 Research Topic

Evaluating the Burden of Pneumococcal Disease in Adults in the United States

An applicant should have a strong research interest within the areas of focus and should consider the following components when developing their research proposals:

A. The burden of pneumococcal disease and serotype distribution in adults including but not limited to:

• Individuals with increased risk of pneumococcal disease including those with underlying comorbidities.

Comorbidities may include but are not limited to:

◦ Diabetes mellitus

◦ Chronic obstructive pulmonary disease (COPD) or other chronic pulmonary disorder

◦ Oncologic disorders

◦ Chronic renal disease

◦ Hepatic disease

◦ Autoimmune disorders

• Those living in community settings (e.g., extended-care facilities, correctional institutions).

• Regional evaluation of pneumococcal resistance and serotype distribution.

• Carriage of Streptococcus pneumoniae in the adult population.

B. Association of pneumococcal pneumonia with influenza or other respiratory viral illnesses

C. The following topics fall outside of the scope of the ASPIRE Adult Vaccine Research Program:

• General education and / or training.

• Support for ongoing clinical programs that are part of an organization’s routine operations.

• Proposals that evaluate populations outside of the United States or Puerto Rico.

Proposals whose primary objective is to financially quantify outcomes as it relates to a Pfizer product(s) are outside the scope of the program.

Research Expectations

Within the specified patient populations of interest, investigators are expected to:

• Generate data regarding the burden of pneumococcal disease in adults and/or evaluation of adult vaccination efforts.

• Be able to complete the research in 12 months.

• Present and/or publish the results of the study.

Available Awards

Pfizer is funding research awards up to a maximum of $100,000 USD* each (including direct costs, institutional overhead costs, and indirect costs) for one year to conduct research generating data that will lead to a better understanding of burden of pneumococcal disease in adults.

*Please note that study budgets will be evaluated separately to ensure the requested funding is commensurate with the work proposed.

Deadline for Application

Applications must be received by 11:59pm EST on July 2, 2013. 

Call for Applications: American Diabetes Association Pathway to Stop Diabetes Diabetes Research Accelerator Award

Call for Applications: American Diabetes Association Pathway to Stop Diabetes Diabetes Research Accelerator Award

Application Deadline: August 16, 2013 for January 2014 funding

Awards are designed to support exceptional early-career researchers who have distinguished themselves as promising investigators and are in the beginning stages of establishing successful, independent diabetes research programs; and talented established investigators in fields other than diabetes who are interested in applying their skills and expertise to diabetes research.

Eligibility:

Awards are available to individuals with established records of independent productivity in research, in two distinct categories:

• Early Investigator: Early-career diabetes investigators proposing innovative and ambitious diabetes-related research programs. Applicants must hold faculty positions and have demonstrated independent productivity in diabetes research. Applicants may currently hold independent NIH funding (K or R awards, including an initial R01) but must not have applied for, or received, an R01 renewal or a second R01 award.

• Established Investigator New to Diabetes Research: Established investigators with exceptional productivity in fields other than diabetes research who would like to apply their expertise to innovative diabetes-related research topics. Applicants must hold faculty positions and have demonstrated independent productivity. Applicants cannot have previously received national grant support in diabetes research.

Candidates will be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.

Support: Awards provide five years of research support at a maximum of $325,000 per year (including 30% indirect costs), for a total of $1,625,000.

Call for Applications: American Diabetes Association Pathway to Stop Diabetes Diabetes Research Career Initiator Award

Call for Applications: American Diabetes Association Pathway to Stop Diabetes Diabetes Research Career Initiator Award

Application Deadline: August 16, 2013 for January 2014 funding

This two-phased award is designed to support the transition from mentored training to independent research faculty

Eligibility:

Eligible applicants must currently be in research training positions (post-doctoral fellow, research fellowship) and have no more than seven years of training following terminal doctoral degree.

Candidates will be identified through institutional nomination; applications will be accepted only from individuals with the appropriate institution support.

Support:

Awards provide two distinct phases of research support. Phase 1 provides up to two years of support for mentored training at a maximum of $100,000 per year (including 10% indirect costs). Phase 2 provides up to five years of support for independent research at a maximum of $325,000 per year (including 30% indirect costs).

Combined support for Phase 1 and Phase 2 can total up to $1,625,000.

Pages